These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31746445)

  • 1. Comparability in Cross-National Health Research Using Insurance Claims Data: The Cases of Germany and The Netherlands.
    Hrzic R; Clemens T; Westra D; Brand H
    Gesundheitswesen; 2020 Mar; 82(S 01):S83-S90. PubMed ID: 31746445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registry and health insurance claims data in vascular research and quality improvement.
    Behrendt CA; Heidemann F; Rieß HC; Stoberock K; Debus SE
    Vasa; 2017 Jan; 46(1):11-15. PubMed ID: 27871211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status and perspectives of claims data analyses in Germany-A systematic review.
    Kreis K; Neubauer S; Klora M; Lange A; Zeidler J
    Health Policy; 2016 Feb; 120(2):213-26. PubMed ID: 26826756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pressure ulcer in German Nursing Homes: Quality Assessment Using Claims Data of Statutory Health and Long-Term Care Insurance].
    Behrendt S; Schwinger A; Tsiasioti C; Stieglitz K; Klauber J
    Gesundheitswesen; 2020 Mar; 82(S 01):S52-S61. PubMed ID: 32018313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overutilization of ambulatory medical care in the elderly German population?--An empirical study based on national insurance claims data and a review of foreign studies.
    van den Bussche H; Kaduszkiewicz H; Schäfer I; Koller D; Hansen H; Scherer M; Schön G
    BMC Health Serv Res; 2016 Apr; 16():129. PubMed ID: 27074709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of an algorithm for the identification of breast cancer deaths in German health insurance claims data: a validation study based on a record linkage with administrative mortality data.
    Langner I; Ohlmeier C; Haug U; Hense HW; Czwikla J; Zeeb H
    BMJ Open; 2019 Jul; 9(7):e026834. PubMed ID: 31350240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementary health insurance as a tool for risk-selection in mandatory basic health insurance markets.
    Paolucci F; Schut E; Beck K; Gress S; Van de Voorde C; Zmora I
    Health Econ Policy Law; 2007 Apr; 2(Pt 2):173-92. PubMed ID: 18634661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can premium differentiation counteract adverse selection in the Dutch supplementary health insurance? A simulation study.
    van Winssen KPM; van Kleef RC; van de Ven WPMM
    Eur J Health Econ; 2018 Jun; 19(5):757-768. PubMed ID: 28762051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk equalization in The Netherlands: an empirical evaluation.
    Van Kleef RC; Van Vliet RC; Van de Ven WP
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):829-39. PubMed ID: 24175733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and external validity of the German Health Risk Institute (HRI) Database.
    Andersohn F; Walker J
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):106-9. PubMed ID: 26530279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage rate between data from health checks and health insurance claims in the Japan National Database.
    Okamoto E
    J Epidemiol; 2014; 24(1):77-83. PubMed ID: 24317344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severity assessment strategies based on administrative data using stroke as an example].
    Schubert I; Hammer A; Köster I
    Z Evid Fortbild Qual Gesundhwes; 2017 Oct; 126():66-75. PubMed ID: 28807634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving risk equalization for individuals with persistently high costs: Experiences from the Netherlands.
    Eijkenaar F; van Vliet RCJA
    Health Policy; 2017 Nov; 121(11):1169-1176. PubMed ID: 28942090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimating the incidence of venous thromboembolism (VTE) using various types of routine data of the German healthcare system].
    Ohlmeier C; Leverkus F; Kloss S; Basic E; Bleß HH
    Z Evid Fortbild Qual Gesundhwes; 2018 Dec; 139():46-52. PubMed ID: 30477975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data Privacy Compliant Validation of Health Insurance Claims Data: the IDOMENEO Approach.
    Behrendt CA; Schwaneberg T; Hischke S; Müller T; Petersen T; Marschall U; Debus S; Kriston L
    Gesundheitswesen; 2020 Mar; 82(S 02):S94-S100. PubMed ID: 31121613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary data, claims data, and linked data in observational research: the case of COPD in Germany.
    Mueller S; Gottschalk F; Groth A; Meeraus W; Driessen M; Kohlmann T; Wilke T
    Respir Res; 2018 Aug; 19(1):161. PubMed ID: 30165860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plan responses to diagnosis-based payment: Evidence from Germany's morbidity-based risk adjustment.
    Bauhoff S; Fischer L; Göpffarth D; Wuppermann AC
    J Health Econ; 2017 Dec; 56():397-413. PubMed ID: 29248063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Outcomes After TKA: Do All Databases Produce Similar Findings?
    Bedard NA; Pugely AJ; McHugh M; Lux N; Otero JE; Bozic KJ; Gao Y; Callaghan JJ
    Clin Orthop Relat Res; 2018 Jan; 476(1):52-63. PubMed ID: 29529616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administrative and claims records as sources of health care cost data.
    Riley GF
    Med Care; 2009 Jul; 47(7 Suppl 1):S51-5. PubMed ID: 19536019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of insurance claims databases in drug therapy outcomes research.
    Lewis NJ; Patwell JT; Briesacher BA
    Pharmacoeconomics; 1993 Nov; 4(5):323-30. PubMed ID: 10146871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.